Musa, Baby Girl .

HRN: 26-46-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
AMPICILLIN 250MG (VIAL)
12/30/2024
01/06/2025
IV
250
Q6
Pcap C
Waiting Final Action 
12/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/30/2024
01/06/2025
IV
75
Q24
Pcap C
Waiting Final Action 
12/30/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/30/2024
01/06/2025
IV DRIP
400mg
Q6
PCAP C
Waiting Final Action 
01/01/2025
MUPIROCIN 2%, 15G (TUBE)
01/01/2025
01/07/2025
TOPICAL
2%
BID
Infiltrated IV Site
Waiting Final Action 
01/03/2025
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
01/03/2025
01/06/2025
PO
1 Ml
Q8h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: